Fortnightly Review: Drug treatment of Parkinson's disease

Effects of Tocopherol and Deprenyl on the Progression of Disability in Early Parkinson's Disease

1993 • 1,208 citations

Effect of Deprenyl on the Progression of Disability in Early Parkinson's Disease

1989 • 913 citations

"ON-OFF" EFFECTS IN PATIENTS WITH PARKINSON'S DISEASE ON CHRONIC LEVODOPA THERAPY

1976 • 651 citations

Young onset Parkinson's disease

1987 • 436 citations

Neurosurgical horizons in Parkinson's disease

1993 • 407 citations

Early development of levodopa‐induced dyskinesias and response fluctuations in young‐onset Parkinson's disease

1991 • 289 citations

Effect of peripheral catechol‐O‐methyltransferase inhibition on the pharmacokinetics and pharmacodynamics of levodopa in parkinsonian patients

1994 • 246 citations

Modification of central dopaminergic mechanisms by continuous levodopa therapy for advanced Parkinson's disease

1990 • 233 citations

A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five year follow up.

1994 • 203 citations

Subcutaneous apomorphine in parkinson's disease: Response to chronic administration for up to five years

1993 • 201 citations

Cholinergic‐dependent cognitive deficits in Parkinson's disease

1987 • 177 citations

Early combination of bromocriptine and levodopa in the treatment of Parkinson's disease

1987 • 168 citations

Dystonia in parkinson's disease: Clinical and pharmacological features

1988 • 156 citations

Clozapine in the treatment of psychosis in Parkinson's disease

1989 • 148 citations

The spectrum of levodopa‐related fluctuations in Parkinson's disease

1993 • 141 citations

Mood swings associated with the ‘on—off’ phenomenon in Parkinson's disease

1987 • 139 citations

Early combination therapy (bromocriptine and levodopa) does not prevent motor fluctuations in Parkinson's disease

1993 • 134 citations

Confusion, dementia and anticholinergics in Parkinson's disease.

1982 • 134 citations

Lisuride, a dopamine agonist in the treatment of early Parkinson's disease

1989 • 131 citations

Catechol‐O‐methyltransferase inhibitor tolcapone prolongs levodopa/carbidopa action in parkinsonian patients

1993 • 95 citations

Onset and End-of-Dose Levodopa-Induced Dyskinesias

1978 • 90 citations

Protein redistribution diet restores motor function in patients with dopa‐resistant “off” periods

1988 • 56 citations

The Sydney Multicentre Study of Parkinson's disease: a report on the first 3 years.

1989 • 41 citations

Transferrin C Subtypes and Myocardial Infarction

1993 • 35 citations

New strategies in dopaminergic therapy of Parkinson's disease: the use of a controlled-release formulation.

1989 • 26 citations

Long-term bromocriptine treatment of de novo patients with Parkinson's disease. A seven-year follow-up

2009 • 22 citations

Drug treatment of Parkinson's disease: is "polypharmacy" best?

1994 • 13 citations

Meeting a need.

1993 • 6 citations